What Does Restorbio Do?

Total employees19
HeadquartersBoston
Founded2016

Restorbio, Inc. was a clinical-stage biopharmaceutical company dedicated to developing innovative therapeutics to target the biology of aging and improve the lives of patients with aging-related diseases. Their primary focus was on the TORC1 pathway, with a lead candidate RTB101. In late 2020, Restorbio merged with Adicet Bio, Inc., and the combined company now operates under the Adicet Bio name, focusing on allogeneic gamma delta T cell therapies for cancer.

Where Is Restorbio's Headquarters?

HQ Function

Served as the central hub for corporate operations, clinical development, research strategy, and administrative functions prior to the company's merger.

Notable Features:

Located in a prominent office building in Boston, providing modern facilities suitable for a biopharmaceutical company's executive and research planning needs. Specific architectural details are not widely publicized.

Work Culture:

As a clinical-stage biotech, the culture likely emphasized scientific innovation, a fast-paced environment, collaboration, and a strong focus on research milestones and patient outcomes.

HQ Significance:

The Boston headquarters was pivotal for Restorbio's strategic decision-making, investor relations, and coordination of its clinical trials aimed at addressing aging-related diseases.

Values Reflected in HQ: The Boston headquarters reflected Restorbio's commitment to operating within a leading biotechnology hub, fostering innovation, and attracting specialized talent for its research and development in aging-related diseases.

Location:

Restorbio's operations were primarily centered in the United States, focusing on research, clinical development, and corporate activities. While their therapeutic targets had global relevance, their direct physical presence was concentrated in the US. Clinical trials for its programs may have involved international sites.

Street Address:

200 Berkeley Street, 18th Floor

City:

Boston

State/Province:

MA

Country:

USA

Where Else Does Restorbio Operate Around the World?

No additional office locations available.

Buying Intent Signals for Restorbio

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Restorbio? Meet the Executive Team

As of April 2025, Restorbio' leadership includes:

Chen Schor - President and Chief Executive Officer
Joan Mannick, M.D. - Co-Founder and Chief Medical Officer
Lloyd Klickstein, M.D., Ph.D. - Chief Scientific Officer
Syam S. Pannala, Ph.D., M.B.A. - Senior Vice President, Technical Operations
Kerry Russell, M.D., Ph.D. - Vice President of Clinical Development

Who's Investing in Restorbio?

Restorbio has been backed by several prominent investors over the years, including:

OrbiMed
Novartis Venture Fund
Fidelity Management & Research Company
Rock Springs Capital
Quan Capital
PureTech Health (initial backer/spin-off source)

What Leadership Changes Has Restorbio Seen Recently?

Hire1
Exits1

In the 12 months leading up to its merger in September 2020, Restorbio saw key executive changes, including a new VP appointment and a notable departure, as it navigated its clinical programs and eventual combination with Adicet Bio. The CEO also transitioned to lead the new combined entity.

Departures

John L. R. M. Cefaly, Ph.D., J.D., John Cefaly departed from his role as General Counsel at Restorbio.

New Appointments:

Kerry Russell, M.D., Ph.D., Kerry Russell was appointed as VP of Clinical Development at Restorbio.
Chen Schor, Chen Schor, formerly CEO of Restorbio, transitioned to become President and CEO of Adicet Bio following the merger.

What Technology (Tech Stack) Is Used byRestorbio?

Discover the tools Restorbio uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Restorbio Email Formats and Examples

Prior to its merger, Restorbio, Inc. likely used common corporate email formats. Standard patterns for biopharmaceutical companies include first initial followed by last name ([flast]@domain.com) or first name followed by a period then last name ([first].[last]@domain.com).

f[last]@restorbio.com or [first].[last]@restorbio.com

Format

jsmith@restorbio.com or jane.doe@restorbio.com

Example

65%

Success rate

What's the Latest News About Restorbio?

GlobeNewswire (Adicet Bio Press Release) • September 29, 2020

Restorbio Completes Merger with Adicet Bio

Restorbio, Inc. announced the completion of its merger with Adicet Bio, Inc. The combined company, operating as Adicet Bio, focuses on the development of allogeneic gamma delta T cell therapies for cancer and began trading on Nasdaq under the ticker symbol 'ACET'....more

FierceBiotech (reporting on company announcement) • November 15, 2019

Restorbio's Lead Drug Candidate RTB101 Fails Phase 3 Clinical Trial

Restorbio announced that its lead drug candidate, RTB101 (an oral TORC1 inhibitor), did not meet the primary endpoint in a Phase 3 clinical trial aimed at preventing respiratory tract infections in elderly patients. This outcome significantly impacted the company's stock and future strategic plans....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Restorbio, are just a search away.